NCT06248970

The Effect of Intermittent Oro-esophageal Tube Feeding on Severe Traumatic Brain Injury Patients With Tracheostomy

Name: Clinical Trial NCT06248970
Creator: Zeng Changhao
Keywords: Traumatic Brain Injury, Rehabilitation therapy, behavioral, clinical trial, China

A Randomized Controlled Study to Explore Effect of Intermittent Oro-esophageal Tube Feeding on Severe Traumatic Brain Injury Patients With Tracheostomy

Zeng Changhao·ClinicalTrials.gov·behavioralTerminated

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Traumatic Brain Injury
Drug/Device/Intervention: Rehabilitation therapy
Study type: Interventional
Intervention type: behavioral

Sponsor & location

Primary sponsor: Zeng Changhao
Funder: People's Hospital of Zhengzhou University
Location: Zhenzhou, China

Timeline & enrollment

Phase: N/A
Start date: Jun 01, 2022
End date: Jun 15, 2023
Enrollment: 104 participants

Primary outcome

Concentration of hemoglobin,Concentration of albumin,Concentration of prealbumin,Nutritional status-body mass index

Summary

This was a multicenter randomized controlled study of 98 severe Traumatic Brain Injury patients with tracheostomy. Patients enrolled were divided randomly into the observation group with Intermittent Oro-esophageal Tube Feeding (n=50) or the control group with Nasogastric tube feeding (n=48) for enteral nutrition support, respectively. Nutritional status, complications, decannulation of tracheostomy tubes and level of consciousness on day 1 and day 28 were recorded and compared.

ICD-10 classifications

Diffuse brain injuryIntracranial injuryFocal brain injuryIntracranial injury, unspecifiedOther intracranial injuries

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT06248970
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT06248970 through Pure Global AI's free database. This phase not specified trial is sponsored by Zeng Changhao and is currently Terminated. The study focuses on Traumatic Brain Injury. Target enrollment is 104 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.